ImmuCell Corporation
56 Evergreen Drive
Portland
Maine
04103-1066
United States
Tel: 207-878-2770
143 articles about ImmuCell Corporation
-
ImmuCell Announces Unaudited Financial Results for the Quarter and Year Ended December 31, 2023
2/27/2024
ImmuCell Corporation (Nasdaq: ICCC) (“ImmuCell” or the “Company”), a growing animal health company that develops, manufactures and markets scientifically proven and practical products that improve the health and productivity of dairy and beef cattle, today announced its unaudited financial results for the quarter and year ended December 31, 2023.
-
ImmuCell to Announce Unaudited Financial Results for the Quarter and Year Ended December 31, 2023Conference Call Scheduled for Wednesday, February 28, 2024 at 9:00 AM ET
2/16/2024
ImmuCell Corporation, a growing animal health company that develops, manufactures and markets scientifically proven and practical products that improve the health and productivity of dairy and beef cattle, expects to report unaudited financial results for the quarter and year ended December 31, 2023 after the market closes on Tuesday, February 27, 2024.
-
ImmuCell Announces Preliminary, Unaudited Sales Results for Q4 2023
1/8/2024
ImmuCell Corporation, a growing animal health company that develops, manufactures and markets scientifically proven and practical products that improve the health and productivity of dairy and beef cattle, announced preliminary, unaudited sales results for the fourth quarter of 2023, which ended December 31, 2023.
-
ImmuCell Announces Unaudited Financial Results for the Quarter Ended September 30, 2023
11/13/2023
ImmuCell Corporation, a growing animal health company that develops, manufactures and markets scientifically proven and practical products that improve the health and productivity of dairy and beef cattle, announced its unaudited financial results for the quarter ended September 30, 2023.
-
ImmuCell to Announce Unaudited Financial Results for the Quarter Ended September 30, 2023
11/7/2023
ImmuCell Corporation expects to report unaudited financial results for the quarter ended September 30, 2023 after the market closes on Monday, November 13, 2023.
-
ImmuCell Announces Preliminary, Unaudited Sales Results for Q3 2023
10/5/2023
ImmuCell Corporation announced preliminary, unaudited sales results for the third quarter of 2023, which ended September 30, 2023.
-
ImmuCell Announces Submission of CMC Technical Section to the FDA
8/29/2023
ImmuCell Corporation announced that it recently submitted the Chemistry, Manufacturing and Controls Technical Section for Re-Tain® to the FDA.
-
ImmuCell Announces Unaudited Financial Results for the Quarter Ended June 30, 2023
8/10/2023
ImmuCell Corporation, a growing animal health company that develops, manufactures and markets scientifically proven and practical products that improve the health and productivity of dairy and beef cattle, announced its unaudited financial results for the quarter ended June 30, 2023.
-
ImmuCell to Announce Unaudited Financial Results for the Quarter Ended June 30, 2023
8/7/2023
ImmuCell Corporation, a growing animal health company that develops, manufactures and markets scientifically proven and practical products that improve the health and productivity of dairy and beef cattle, expects to report unaudited financial results for the quarter ended June 30, 2023 after the market closes on Thursday, August 10, 2023.
-
ImmuCell Announces Preliminary, Unaudited Sales Results for Q2 2023
7/11/2023
ImmuCell Corporation announced preliminary, unaudited sales results for the second quarter of 2023, which ended June 30, 2023.
-
ImmuCell Announces Change in Timing of Anticipated FDA Submission
6/28/2023
ImmuCell Corporation announced a change to its anticipated FDA submission schedule.
-
ImmuCell Appoints Bryan K. Gathagan to Board of Directors
6/21/2023
ImmuCell Corporation, a growing animal health company that develops, manufactures and markets scientifically proven and practical products that improve the health and productivity of dairy and beef cattle, announced that Bryan K. Gathagan has been appointed to its Board of Directors.
-
ImmuCell Announces Approval of Principal Terms of a $3 Million Debt Facility
6/15/2023
ImmuCell Corporation, a growing animal health company that develops, manufactures and markets scientifically proven and practical products that improve the health and productivity of dairy and beef cattle, announced the approval by Gorham Savings Bank and the Finance Authority of Maine of the principal terms of a $3 million debt facility with the Company.
-
ImmuCell to Hold Virtual-Only Annual Meeting of Stockholders - May 16, 2023
5/16/2023
ImmuCell Corporation, a growing animal health company that develops, manufactures and markets scientifically proven and practical products that improve the health and productivity of dairy and beef cattle, announced that its 2023 Annual Meeting of Stockholders will be conducted virtually.
-
ImmuCell Announces Unaudited Financial Results for the Quarter Ended March 31, 2023
5/11/2023
ImmuCell Corporation, a growing animal health company that develops, manufactures and markets scientifically proven and practical products that improve the health and productivity of dairy and beef cattle, announced its unaudited financial results for the quarter ended March 31, 2023.
-
ImmuCell to Announce Unaudited Financial Results for the Quarter Ended March 31, 2023
5/4/2023
ImmuCell Corporation, a growing animal health company that develops, manufactures and markets scientifically proven and practical products that improve the health and productivity of dairy and beef cattle, expects to report unaudited financial results for the quarter ended March 31, 2023 after the market closes on Thursday, May 11, 2023.
-
ImmuCell Announces Preliminary, Unaudited Sales Results for Q1 2023
4/5/2023
ImmuCell Corporation, a growing animal health company that develops, manufactures and markets scientifically-proven and practical products that improve the health and productivity of dairy and beef cattle, announced preliminary, unaudited sales results for the first quarter of 2023, which ended March 31, 2023.
-
ImmuCell Announces Unaudited Financial Results for the Year Ended December 31, 2022
2/21/2023
ImmuCell Corporation announced its unaudited financial results for the year ended December 31, 2022.
-
ImmuCell to Announce Unaudited Financial Results for the Year Ended December 31, 2022
2/15/2023
ImmuCell Corporation, a growing animal health company that develops, manufactures and markets scientifically-proven and practical products that improve the health and productivity of dairy and beef cattle, expects to report unaudited financial results for the year ended December 31, 2022 after the market closes on Tuesday, February 21, 2023.
-
ImmuCell Announces Preliminary, Unaudited Sales Results for the Year Ended December 31, 2022
1/9/2023
ImmuCell Corporation announced preliminary, unaudited sales results for the year ended December 31, 2022.